Site-specific trastuzumab Fab-DM1 via butelase-1 with ABD fusion for potent HER2-positive tumor control.
Saved in:
| Title: | Site-specific trastuzumab Fab-DM1 via butelase-1 with ABD fusion for potent HER2-positive tumor control. |
|---|---|
| Authors: | Han Y; Longhu Laboratory of Advanced Immunology, School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, P.R. China., Guo Q; Longhu Laboratory of Advanced Immunology, School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, P.R. China.; School of Basic Medicine, Henan University of Chinese Medicine, Zhengzhou, 450046, Henan, P.R. China., Cao H; Longhu Laboratory of Advanced Immunology, School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, P.R. China., Qin T; Longhu Laboratory of Advanced Immunology, School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, P.R. China., Zhang X; Longhu Laboratory of Advanced Immunology, School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, P.R. China., Dong Q; Longhu Laboratory of Advanced Immunology, School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, P.R. China., Huang Y; Clinical Systems Biology Laboratories, Translational Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Hanan, P.R. China., Mao Y; Longhu Laboratory of Advanced Immunology, School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, P.R. China., Wang Z; Longhu Laboratory of Advanced Immunology, School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, P.R. China., Liu Q; School of Life Sciences, Henan Institute of Science and Technology, Xinxiang, 453003, Henan, P.R. China., Liu Y; Longhu Laboratory of Advanced Immunology, School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, P.R. China. liuyangxue1224@zzu.edu.cn., Zhang S; Longhu Laboratory of Advanced Immunology, School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, P.R. China. zhangst@zzu.edu.cn.; School of Life Sciences, Henan Institute of Science and Technology, Xinxiang, 453003, Henan, P.R. China. zhangst@zzu.edu.cn. |
| Source: | Medical oncology (Northwood, London, England) [Med Oncol] 2026 Jul 01; Vol. 43 (8). Date of Electronic Publication: 2026 Jul 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42384122 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Site-specific trastuzumab Fab-DM1 via butelase-1 with ABD fusion for potent HER2-positive tumor control. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Han+Y%22">Han Y</searchLink>; Longhu Laboratory of Advanced Immunology, School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, P.R. China.<br /><searchLink fieldCode="AU" term="%22Guo+Q%22">Guo Q</searchLink>; Longhu Laboratory of Advanced Immunology, School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, P.R. China.; School of Basic Medicine, Henan University of Chinese Medicine, Zhengzhou, 450046, Henan, P.R. China.<br /><searchLink fieldCode="AU" term="%22Cao+H%22">Cao H</searchLink>; Longhu Laboratory of Advanced Immunology, School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, P.R. China.<br /><searchLink fieldCode="AU" term="%22Qin+T%22">Qin T</searchLink>; Longhu Laboratory of Advanced Immunology, School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, P.R. China.<br /><searchLink fieldCode="AU" term="%22Zhang+X%22">Zhang X</searchLink>; Longhu Laboratory of Advanced Immunology, School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, P.R. China.<br /><searchLink fieldCode="AU" term="%22Dong+Q%22">Dong Q</searchLink>; Longhu Laboratory of Advanced Immunology, School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, P.R. China.<br /><searchLink fieldCode="AU" term="%22Huang+Y%22">Huang Y</searchLink>; Clinical Systems Biology Laboratories, Translational Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Hanan, P.R. China.<br /><searchLink fieldCode="AU" term="%22Mao+Y%22">Mao Y</searchLink>; Longhu Laboratory of Advanced Immunology, School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, P.R. China.<br /><searchLink fieldCode="AU" term="%22Wang+Z%22">Wang Z</searchLink>; Longhu Laboratory of Advanced Immunology, School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, P.R. China.<br /><searchLink fieldCode="AU" term="%22Liu+Q%22">Liu Q</searchLink>; School of Life Sciences, Henan Institute of Science and Technology, Xinxiang, 453003, Henan, P.R. China.<br /><searchLink fieldCode="AU" term="%22Liu+Y%22">Liu Y</searchLink>; Longhu Laboratory of Advanced Immunology, School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, P.R. China. liuyangxue1224@zzu.edu.cn.<br /><searchLink fieldCode="AU" term="%22Zhang+S%22">Zhang S</searchLink>; Longhu Laboratory of Advanced Immunology, School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, P.R. China. zhangst@zzu.edu.cn.; School of Life Sciences, Henan Institute of Science and Technology, Xinxiang, 453003, Henan, P.R. China. zhangst@zzu.edu.cn. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229435512%22">Medical oncology (Northwood, London, England)</searchLink> [Med Oncol] 2026 Jul 01; Vol. 43 (8). <i>Date of Electronic Publication: </i>2026 Jul 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9435512 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1559-131X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213570560%22">13570560 </searchLink><i>NLM ISO Abbreviation: </i>Med Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42384122 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s12032-026-03317-3 Languages: – Code: eng Text: English Titles: – TitleFull: Site-specific trastuzumab Fab-DM1 via butelase-1 with ABD fusion for potent HER2-positive tumor control. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Han Y – PersonEntity: Name: NameFull: Guo Q – PersonEntity: Name: NameFull: Cao H – PersonEntity: Name: NameFull: Qin T – PersonEntity: Name: NameFull: Zhang X – PersonEntity: Name: NameFull: Dong Q – PersonEntity: Name: NameFull: Huang Y – PersonEntity: Name: NameFull: Mao Y – PersonEntity: Name: NameFull: Wang Z – PersonEntity: Name: NameFull: Liu Q – PersonEntity: Name: NameFull: Liu Y – PersonEntity: Name: NameFull: Zhang S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2026 Jul 01 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1559-131X Numbering: – Type: volume Value: 43 – Type: issue Value: 8 Titles: – TitleFull: Medical oncology (Northwood, London, England) Type: main |
| ResultId | 1 |